Free access to medicines for the treatment of chronic diseases in brazil
| Autor(a) principal: | |
|---|---|
| Data de Publicação: | 2016 |
| Outros Autores: | , , , , , , , , |
| Tipo de documento: | Artigo |
| Idioma: | eng |
| Título da fonte: | Repositório Institucional da UNIFESP |
| Texto Completo: | http://dx.doi.org/10.1590/s1518-8787.2016050006118 http://repositorio.unifesp.br/handle/11600/49282 |
Resumo: | OBJECTIVE: To analyze the free access to medicines for the treatment of chronic diseases in the Brazilian population, according to demographic and socioeconomic factors. We also analyzed the most used pharmacological groups, according to funding source: free-of-charge or out-of-pocket paid. METHODS: Analysis of data from the Pesquisa Nacional sobre Acesso, Utilizacao e Promocao do Uso Racional de Medicamentos (PNAUM - National Survey on Access, Use and Promotion of Rational Use of Medicines), a population-based household survey, of cross-sectional design, based on probabilistic sample of the Brazilian population. We analyzed as outcome the prevalence of free access (free-of-charge) to all medicines for treatment of the reported chronic diseases, in the last 30 days. We studied the following independent variables: sex, age group, education in complete years of school, economic class, health plan, and geographical region of residence. We estimated the prevalences and 95% confidence intervals (95% CI) and applied the Pearson's Chi-squared test to assess the differences between the groups, considering a 5% significance level. RESULTS: About half of adults and older adults who have had full access to the treatment of chronic diseases in Brazil obtained all needed medicines for free (47.5% |
| id |
UFSP_6f4cd21f9af9a53c51fc253909ce19f7 |
|---|---|
| oai_identifier_str |
oai:repositorio.unifesp.br/:11600/49282 |
| network_acronym_str |
UFSP |
| network_name_str |
Repositório Institucional da UNIFESP |
| repository_id_str |
3465 |
| spelling |
Free access to medicines for the treatment of chronic diseases in brazilAcesso gratuito a medicamentos para tratamento de doenças crônicas no BrasilMinas-Gerais StateHealth-CareSouthern BrazilBelo-HorizonteExpendituresInequalitiesPrevalenceMedicationSystemDrugsOBJECTIVE: To analyze the free access to medicines for the treatment of chronic diseases in the Brazilian population, according to demographic and socioeconomic factors. We also analyzed the most used pharmacological groups, according to funding source: free-of-charge or out-of-pocket paid. METHODS: Analysis of data from the Pesquisa Nacional sobre Acesso, Utilizacao e Promocao do Uso Racional de Medicamentos (PNAUM - National Survey on Access, Use and Promotion of Rational Use of Medicines), a population-based household survey, of cross-sectional design, based on probabilistic sample of the Brazilian population. We analyzed as outcome the prevalence of free access (free-of-charge) to all medicines for treatment of the reported chronic diseases, in the last 30 days. We studied the following independent variables: sex, age group, education in complete years of school, economic class, health plan, and geographical region of residence. We estimated the prevalences and 95% confidence intervals (95% CI) and applied the Pearson's Chi-squared test to assess the differences between the groups, considering a 5% significance level. RESULTS: About half of adults and older adults who have had full access to the treatment of chronic diseases in Brazil obtained all needed medicines for free (47.5%95% CI 45.1-50.0). The prevalences of free access were higher among men (51.4%95% CI 48.1-54.8), age group of 40-59 years (51.1%95% CI 48.1-54.2), and in the poorest social classes (53.9%95% CI 50.2-57.7). The majority of medicines that act on the cardiovascular system, such as diuretics (C03) (78.0%95% CI 75.2-80.5), beta-blockers (C07) (62.7%95% CI 59.4-65.8), and the agents that work in the renin-angiotensin system (C09) (73.4%95% CI 70.8-75.8), were obtained for free. Medicines that act on the respiratory system, such as agents against obstructive airway diseases (R03) (60.0%95% CI 52.7-66.9) were mostly paid with own resources. CONCLUSIONS: Free access to medicines for treatment of chronic diseases occurs to a considerable portion of the Brazilian population, especially for the poorest ones, indicating decreased socioeconomic inequalities, but with differences between regions and between some classes of medicines.Departamento de Farmácia. Faculdade de Ciências da Saúde. Universidade de Brasília. Brasília, DF, BrasilDepartamento de Política de Medicamentos e Assistência Farmacêutica. Escola Nacional de Saúde Pública Sérgio Arouca. Fundação Oswaldo Cruz. Rio de Janeiro, RJ, BrasilNúcleo de Estudos de Políticas Públicas. Universidade Estadual de Campinas. Campinas, SP, BrasilPrograma de Pós-Graduação em Epidemiologia. Universidade Federal do Rio Grande do Sul. Porto Alegre, RS, BrasilDepartamento de Farmácia. Faculdade de Farmácia, Odontologia e Enfermagem. Universidade Federal do Ceará. Fortaleza, CE, BrasilDepartamento de Medicina Preventiva. Escola Paulista de Medicina. Universidade Federal de São Paulo. São Paulo, SP, BrasilDepartamento de Ciências Farmacêuticas, Centro de Ciências da Saúde. Universidade Federal de Santa Catarina. Florianópolis, SC, BrasilDepartamento de Produção e Controle de Medicamentos. Faculdade de Farmácia. Universidade Federal do Rio Grande do Sul. Porto Alegre, RS, BrasilDepartamento de Medicina Social. Faculdade de Medicina. Universidade Federal de Pelotas. Pelotas, RS, BrasilDepartamento de Medicina Preventiva. Escola Paulista de Medicina. Universidade Federal de São Paulo. São Paulo, SP, BrasilWeb of ScienceDepartment of Pharmaceutical Services and Strategic Health Supplies (DAF) of the Secretariat of Science, Technology and Strategic Inputs (SCTIE) of the Ministry of Health (SCTIE/MS) [25000.111834/2011-31]Department of Science and Technology (DECIT) of the Secretariat of Science, Technology and Strategic Inputs (SCTIE) of the Ministry of Health (SCTIE/MS) [25000.111834/2011-31]SCTIE/MS: 25000.111834/2011-31Dove Medical Press Ltd2019-01-21T10:29:36Z2019-01-21T10:29:36Z2016info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion7shttp://dx.doi.org/10.1590/s1518-8787.2016050006118Revista De Saude Publica. Sao paulo, v. 50, n. 2, p. 7s, 2016.10.1590/S1518-8787.2016050006118S0034-89102016000300313.pdf0034-8910S0034-89102016000300313http://repositorio.unifesp.br/handle/11600/49282WOS:000391447400003engRevista De Saude Publicainfo:eu-repo/semantics/openAccessLeao Tavares, Noemia UrruthLuiza, Vera LuciaOliveira, Maria AuxiliadoraCosta, Karen SarmentoMengue, Sotero SerrateDourado Arrais, Paulo SergioRamos, Luiz Roberto [UNIFESP]Farias, Mareni RochaDal Pizzol, Tatiane da SilvaBertoldi, Andrea Damasoreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2022-02-08T13:01:55Zoai:repositorio.unifesp.br/:11600/49282Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652022-02-08T13:01:55Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
| dc.title.none.fl_str_mv |
Free access to medicines for the treatment of chronic diseases in brazil Acesso gratuito a medicamentos para tratamento de doenças crônicas no Brasil |
| title |
Free access to medicines for the treatment of chronic diseases in brazil |
| spellingShingle |
Free access to medicines for the treatment of chronic diseases in brazil Leao Tavares, Noemia Urruth Minas-Gerais State Health-Care Southern Brazil Belo-Horizonte Expenditures Inequalities Prevalence Medication System Drugs |
| title_short |
Free access to medicines for the treatment of chronic diseases in brazil |
| title_full |
Free access to medicines for the treatment of chronic diseases in brazil |
| title_fullStr |
Free access to medicines for the treatment of chronic diseases in brazil |
| title_full_unstemmed |
Free access to medicines for the treatment of chronic diseases in brazil |
| title_sort |
Free access to medicines for the treatment of chronic diseases in brazil |
| author |
Leao Tavares, Noemia Urruth |
| author_facet |
Leao Tavares, Noemia Urruth Luiza, Vera Lucia Oliveira, Maria Auxiliadora Costa, Karen Sarmento Mengue, Sotero Serrate Dourado Arrais, Paulo Sergio Ramos, Luiz Roberto [UNIFESP] Farias, Mareni Rocha Dal Pizzol, Tatiane da Silva Bertoldi, Andrea Damaso |
| author_role |
author |
| author2 |
Luiza, Vera Lucia Oliveira, Maria Auxiliadora Costa, Karen Sarmento Mengue, Sotero Serrate Dourado Arrais, Paulo Sergio Ramos, Luiz Roberto [UNIFESP] Farias, Mareni Rocha Dal Pizzol, Tatiane da Silva Bertoldi, Andrea Damaso |
| author2_role |
author author author author author author author author author |
| dc.contributor.author.fl_str_mv |
Leao Tavares, Noemia Urruth Luiza, Vera Lucia Oliveira, Maria Auxiliadora Costa, Karen Sarmento Mengue, Sotero Serrate Dourado Arrais, Paulo Sergio Ramos, Luiz Roberto [UNIFESP] Farias, Mareni Rocha Dal Pizzol, Tatiane da Silva Bertoldi, Andrea Damaso |
| dc.subject.por.fl_str_mv |
Minas-Gerais State Health-Care Southern Brazil Belo-Horizonte Expenditures Inequalities Prevalence Medication System Drugs |
| topic |
Minas-Gerais State Health-Care Southern Brazil Belo-Horizonte Expenditures Inequalities Prevalence Medication System Drugs |
| description |
OBJECTIVE: To analyze the free access to medicines for the treatment of chronic diseases in the Brazilian population, according to demographic and socioeconomic factors. We also analyzed the most used pharmacological groups, according to funding source: free-of-charge or out-of-pocket paid. METHODS: Analysis of data from the Pesquisa Nacional sobre Acesso, Utilizacao e Promocao do Uso Racional de Medicamentos (PNAUM - National Survey on Access, Use and Promotion of Rational Use of Medicines), a population-based household survey, of cross-sectional design, based on probabilistic sample of the Brazilian population. We analyzed as outcome the prevalence of free access (free-of-charge) to all medicines for treatment of the reported chronic diseases, in the last 30 days. We studied the following independent variables: sex, age group, education in complete years of school, economic class, health plan, and geographical region of residence. We estimated the prevalences and 95% confidence intervals (95% CI) and applied the Pearson's Chi-squared test to assess the differences between the groups, considering a 5% significance level. RESULTS: About half of adults and older adults who have had full access to the treatment of chronic diseases in Brazil obtained all needed medicines for free (47.5% |
| publishDate |
2016 |
| dc.date.none.fl_str_mv |
2016 2019-01-21T10:29:36Z 2019-01-21T10:29:36Z |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1590/s1518-8787.2016050006118 Revista De Saude Publica. Sao paulo, v. 50, n. 2, p. 7s, 2016. 10.1590/S1518-8787.2016050006118 S0034-89102016000300313.pdf 0034-8910 S0034-89102016000300313 http://repositorio.unifesp.br/handle/11600/49282 WOS:000391447400003 |
| url |
http://dx.doi.org/10.1590/s1518-8787.2016050006118 http://repositorio.unifesp.br/handle/11600/49282 |
| identifier_str_mv |
Revista De Saude Publica. Sao paulo, v. 50, n. 2, p. 7s, 2016. 10.1590/S1518-8787.2016050006118 S0034-89102016000300313.pdf 0034-8910 S0034-89102016000300313 WOS:000391447400003 |
| dc.language.iso.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
Revista De Saude Publica |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
7s |
| dc.publisher.none.fl_str_mv |
Dove Medical Press Ltd |
| publisher.none.fl_str_mv |
Dove Medical Press Ltd |
| dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
| instname_str |
Universidade Federal de São Paulo (UNIFESP) |
| instacron_str |
UNIFESP |
| institution |
UNIFESP |
| reponame_str |
Repositório Institucional da UNIFESP |
| collection |
Repositório Institucional da UNIFESP |
| repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
| repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
| _version_ |
1814268425679142912 |